Document ID: chunk:federal_register_of_legislation:F2021L00482:clause:1_1:p1
Version: federal_register_of_legislation:F2021L00482
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 1/2)
Character Range: 9799–13865

1               Definitions
In this instrument:
                               episcleritis means acute or chronic inflammation of the superficial, episcleral layer of the eye ball.
                               equivalent glucocorticoid therapy means a glucocorticoid in the following table, at the doses specified in the table, or a therapeutically equivalent dose of another glucocorticoid:

 Glucocorticoid      Minimum cumulative  Minimum average
                     dose (milligrams)   rate (milligrams/day)

 betamethasone       60                  2
 cortisone           1,875               62.5
 dexamethasone       50                  1.67
 methylprednisolone  300                 10
 paramethasone       150                 5
 prednisone          375                 12.5
 prednisolone        375                 12.5
 triamcinolone       300                 10

                               equivalent inhaled glucocorticoid means:
(a)          8,000 micrograms of triamcinolone;
(b)          1,600 micrograms of budesonide;
(c)          1,000 micrograms of fluticasone; or
(d)          a therapeutically equivalent dose of another inhaled glucocorticoid.
                               glucocorticoid therapy as specified means:
(a)          taking:
(i)             hydrocortisone orally, by injection, or per rectum:
                1. to a cumulative dose of at least 1,500 milligrams; and
                2. at a minimum dose rate averaging 50 milligrams per day; or
(ii)          equivalent glucocorticoid therapy orally, by injection, or per rectum; or
(b)           inhaling at least 1,600 micrograms of beclomethasone, or equivalent inhaled glucocorticoid, daily for at least four weeks; or
(c)           using a topical ocular glucocorticoid to the affected eye daily for at least two weeks; or
(d)          using an intranasal glucocorticoid at above the maximum therapeutic dosage level daily for at least four weeks; or
(e)           having an intraocular or periocular glucocorticoid injection to the affected eye; or
(f)            applying a topical glucocorticoid to the face daily for at least four weeks; or
(g)           applying a high or very high potency topical glucocorticoid to at least 20% of total skin surface area, daily, for at least four weeks.
        Note: equivalent glucocorticoid therapy, equivalent inhaled glucocorticoid and high or very high potency topical glucocorticoid are also defined in the Schedule 1 - Dictionary.
                               high or very high potency topical glucocorticoid means:
(a)          betamethasone dipropionate 0.05%;
(b)          betamethasone valerate 0.1%;
(c)          clobetasol proprionate 0.05%;
(d)          diflucortolone valerate 0.1%;
(e)          fluocinolone acetonide 0.025%; or
(f)           another topical glucocorticoid of equivalent potency.
                                  MRCA means the Military Rehabilitation and Compensation Act 2004.
                               open-angle glaucoma—see subsection 7(2).
                                  relevant service means:
(a)          eligible war service (other than operational service) under the VEA;
(b)          defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
(c)          peacetime service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
                               scleritis means acute or chronic inflammation that affects the white outer coating of the eye ball.
                               specified list of conditions or procedures means:
(a)          carotid endarterectomy;
(b)          diabetic retinopathy;
(c)          intraocular surgery;
(d)          intraocular tumour;
(e)          carotid artery disease;
(f)           radiotherapy;
(g)          retinal detachment;
(h)          retinal vascular occlusion;
(i)            retinal vasculitis; or
(j)            another acquired condition causing posterior segment ischaemia.
                               sympathetic ophthalmia means